11 million Americans (of which over 829,000 are aged 0-17) take antipsychotics that 20%-50% (2.2 – 5.5 million) could develop an iatrogenic, drug-induced movement disorder…
Huffington Post – March 3, 2014 By Peter Breggin On Feb. 11, 2014, a Chicago jury awarded $1.5 million to an autistic child who developed…
I can’t think of a more fitting first guest for Mental Health Exposed. Our mission is to expose the fraud, abuse and incompetence in the mental health industry, as well as promote natural and effective methods of healing. Peter Breggin, MD and I discuss all of the above in the premier of Mental Health Exposed on Natural News Radio.
Peter R. Breggin, M.D. is a Harvard-trained psychiatrist and former full-time consultant with NIMH who is in private practice in Ithaca, New York. Dr. Breggin is the author of more than twenty books including the bestseller Talking Back to Prozac and the medical book Brain-Disabling Treatments in Psychiatry. His most recent book is Medication Madness, the Role of Psychiatric Drugs in Cases of Violence, Suicide and Crime. He is also the author of dozens of peer-reviewed scientific articles, many in the field of psychopharmacology.
Imagine being a parent taking your 10-year-old daughter to the doctor where she gasps for air and suddenly dies in your arms. You are informed afterwards that a toxic dose of prescribed medication caused her death. Imagine leaving your house to have lunch with friends, while your husband and 11-year-old daughter are happily cuddled together watching your daughter’s favourite TV show Animal Planet. You return home hours later, walk upstairs to her bedroom and find her hanging from the valence of her bed.
Ironically, the FDA is approving these drugs for use in children at the same time that the Justice Department has been fining drug companies for illegally marketing these drugs to children. The illegal marketing corrupted and contaminated medical practice, encouraging physicians to prescribe off label, eventually leading the FDA to then approve off label prescribing. The studies used to justify this approval have been wholly developed and supervised by these same drugs companies using handpicked doctors who have often been involved in encouraging off label use. Drug companies commonly ghostwrite the research publications that appear under the names of these doctors.